Hirai, Toyohiro
Asano, Koichiro
Ito, Isao
Miyazaki, Yasunari
Sugiura, Hisatoshi
Agirbasli, Mehmet
Kobayashi, Seiichi
Kobayashi, Makoto
Shimada, Daishi
Natsume, Ichiro
Kawasaki, Tsutomu
Ohba, Takehiko
Tajiri, Sakurako
Sakamaki, Fumio
Mineshita, Masamichi
Takihara, Takahisa
Sekiya, Kiyoshi
Tomii, Keisuke
Tomioka, Hiromi
Kita, Hideo
Nishizaka, Yasuo
Fukui, Motonari
Miyata, Toshio
Harigae, Hideo
Funding for this research was provided by:
Japan Agency for Medical Research and Development (AMED 20fk0108266h0001)
Article History
Received: 5 June 2023
Accepted: 20 December 2023
First Online: 2 January 2024
Competing interests
: T.H. declares research funding from FUJIFILM Corp. H.S. received compensation as a member of the scientific advisory boards of GlaxoSmithKline K.K. and AstraZeneca and declares research funding from AstraZeneca, and received compensation as payment or honoraria for lectures from Novartis Pharma KK, Kyorin Pharmaceutical Co, Ltd, Sanofi KK, Taiho Pharmaceutical Co, Ltd, GlaxoSmithKline KK, AstraZeneca, and Boehringer Ingelheim. M.A. declares travel expenses and honoraria from Pfizer. T.M. declares research funding from Astellas, Daiichi Sankyo, Kowa, and stocks of Renascience. H.H. declares speakers’ bureau fees and honoraria from Novartis, Chugai, Janssen, and Sanofi. K.S. has received compensation as payment or honoraria for lectures from Novartis Pharma KK, Kyorin Pharmaceutical Co., Ltd., Sanofi KK, Taiho Pharmaceutical Co., Ltd., and GlaxoSmithKline KK. The other authors declare no conflict of interest.